EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and rats



Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and rats



Journal of Hepatology 5(2): 149-153



In order to test the hypothesis that endogenous opioids may mediate some of the circulatory derangements in cirrhosis, we studied the haemodynamic effects of naloxone, an opioid antagonist, in patients and in a rat model of biliary cirrhosis. In 9 patients with alcoholic cirrhosis and 5 control patients without significant liver disease, cardiac output, systemic vascular resistance, mean arterial pressure, heart rate, hepatic venous pressures and O2 content, hepatic and azygos blood flows and serum catecholamines were measured before and 30 min after naloxone 3.2 mg i.v. bolus. No significant changes were observed in either group of patients. Similarly in 16 conscious rats, 8 sham-operated and 8 with cirrhosis due to bile duct ligation, cardiac output, systemic vascular resistance, mean arterial pressure, heart rate, and splanchnic organ blood flows were measured by radioactive microspheres, before and 20 min after naloxone 1 mg/kg i.v. bolus. No significant changes were observed in either group. We failed to detect any evidence that endorphins are involved in tonic haemodynamic control in cirrhosis.

(PDF emailed within 1 workday: $29.90)

Accession: 005956290

Download citation: RISBibTeXText

PMID: 3693858



Related references

Naloxone can alter experimental pain and mood in humans. Physiological Psychology 9(3): 245-250, 1981

Endorphins: naloxone fails to alter experimental pain or mood in humans. Science 199(4333): 1093-1095, 1978

Naloxone does not alter the perception of pain induced by electrical and thermal stimulation of the skin in healthy humans. Pain 34(3): 271-276, 1988

Temporal relationships between cirrhosis portal hypertension and systemic hemodynamics in carbon tetrachloride induced cirrhosis in rats. Hepatology 6(5): 1120, 1986

The influence of naloxone on regional hemodynamics in hemorrhaged rats. Circulatory Shock 16(2): 173-183, 1985

Three different types of alpha-interferons alter naloxone-induced abstinence in morphine-addicted rats. Immunopharmacology 9(1): 13-17, 1985

Immunosuppression by ionizing irradiation prevent and alter naloxone induced withdrawal in morphine addicted rats. Federation Proceedings 44(5): 1491, 1985

Naloxone does not alter amphetamine-induced rotational behavior or striatal dopamine levels of nigrally-lesioned rats. Brain Research. 789(1): 171-174, Il 6, 1998

Simultaneous, study of systemic and regional visceral hemodynamics in cirrhosis. 3. Systemic and hepatosplanchnic hemodynamics in decompensated liver cirrhosis, with ascites. Minerva Medica 58(11): 364-367, 1967

Simultaneous study of systemic and regional visceral hemodynamics in cirrhosis. I. Systemic and hepatosplanchnic hemodynamics in compensated post-necrotic cirrhosis. Minerva Medica 58(11): 355-360, 1967

Simultaneous study of systemic and regional visceral hemodynamics in cirrhosis. II. Systemic and hepatosplanchnic hemodynamics in compensated alcoholic cirrhosis. Minerva Medica 58(11): 360-363, 1967

Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure. Experimental and Clinical Psychopharmacology 6(2): 169-178, 1998

D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure. Experimental and Clinical Psychopharmacology 11(3): 237-246, 2003

Effects of bn 52021 on hemodynamics of rats with experimental cirrhosis of the liver. Prostaglandins 30(4): 717, 1985